A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | May 2012 |
| End Date: | May 2015 |
| Contact: | John Hornberger, MD MS |
| Email: | crc@cedarecon.com |
| Phone: | (888)707-1124 |
A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test
The study prospectively assesses the change in cancer-specific clinical decisions and
outcomes before and after physicians received results from the Pathwork® Tissue of Origin
(TOO) Test for patients whose primary site of cancer origin is uncertain.
Inclusion Criteria:
- their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and
December 2013
- the patient is ≥ 18 years of age
- the patient has given informed consent (online or verbal)
- the patient is able to understand English.
We found this trial at
1
site
Click here to add this to my saved trials
